Treatment recommendations for metastatic colorectal cancer

被引:19
|
作者
Aranda, Enrique [1 ]
Abad, Albert [2 ]
Carrato, Alfredo [3 ]
Cervantes, Andres [4 ]
Garcia-Foncillas, Jesus [5 ]
Garcia Alfonso, Pilar [6 ]
Garcia Carbonero, Rocio [7 ]
Gomez Espana, Auxiliadora [1 ]
Tabernero, Josep M. [8 ]
Diaz-Rubio, Eduardo [9 ]
机构
[1] Hosp Univ Reina Sofia, Dept Med Oncol, ES-14004 Cordoba, Spain
[2] Hosp Germans Trias & Pujol ICO, Barcelona, Spain
[3] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[4] Hosp Clin, Valencia, Spain
[5] Clin Navarra, Navarra, Spain
[6] Hosp Gen Gregorio Maranon, Madrid, Spain
[7] Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBIS, Seville, Spain
[8] Hosp Valle De Hebron, Barcelona, Spain
[9] Hosp Clin San Carlos, Madrid, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2011年 / 13卷 / 03期
关键词
Metastatic colorectal cancer; Chemotherapy; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; CETUXIMAB PLUS IRINOTECAN; PHASE-III TRIAL; CIRCULATING TUMOR-CELLS; HIGH-DOSE LEUCOVORIN; CONTINUOUS-INFUSION FLUOROURACIL; THYMIDYLATE SYNTHASE EXPRESSION; COMPLETE CYTOREDUCTIVE SURGERY; RESECTABLE LIVER METASTASES; SPANISH COOPERATIVE GROUP;
D O I
10.1007/s12094-011-0636-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Metastatic colorectal cancer (CRC) represents an important health problem in which several biological predictive and prognostic factors have been identified, including clinical features and molecular markers that might influence the response to treatment. Actually, certain prognostic factors are considered key elements, along with disease extent, for deciding the therapeutic approach. However, a distinction between resectable/potentially resectable and unresectable patients must be made in order to establish an adequate therapeutic strategy. Different drugs and chemotherapy regimens are currently available, and their administration depends on patient characteristics, disease-related factors and the treatment objective. Moreover, special situations such as peritoneal carcinomatosis and local treatment of CRC in the setting of metastatic disease should be considered when deciding the most appropriate treatment strategy. This article reviews all the previously mentioned issues involved in the management of metastatic CRC and suggests some general recommendations for its treatment.
引用
收藏
页码:162 / 178
页数:17
相关论文
共 50 条
  • [1] Treatment recommendations for metastatic colorectal cancer
    Enrique Aranda
    Albert Abad
    Alfredo Carrato
    Andrés Cervantes
    Jesús García-Foncillas
    Pilar García Alfonso
    Rocío García Carbonero
    Auxiliadora Gómez España
    Josep M. Tabernero
    Eduardo Díaz-Rubio
    [J]. Clinical and Translational Oncology, 2011, 13 : 162 - 178
  • [2] Treatment of Metastatic Colorectal Cancer
    Davies, Janine M.
    Goldberg, Richard M.
    [J]. SEMINARS IN ONCOLOGY, 2011, 38 (04) : 552 - 560
  • [3] The treatment of metastatic colorectal cancer
    Karapetis, CS
    Yip, D
    Harper, PG
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (04) : 287 - 294
  • [4] Cetuximab - In the treatment of metastatic colorectal cancer
    Reynolds, NA
    Wagstaff, AJ
    [J]. DRUGS, 2004, 64 (01) : 109 - 118
  • [5] Maintenance treatment for metastatic colorectal cancer
    Mahaseth, Hemchandra
    Shields, Anthony F.
    [J]. COLORECTAL CANCER, 2014, 3 (06) : 501 - 520
  • [6] Updates in the Treatment of Metastatic Colorectal Cancer
    Malla, Midhun
    Pedersen, Katrina S.
    Parikh, Aparna R.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 567 - 571
  • [7] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256
  • [8] Maintenance treatment in metastatic colorectal cancer
    Simkens, Lieke H. J.
    van Tinteren, Harm
    Punt, Cornelis J. A.
    Koopman, Miriam
    [J]. LANCET ONCOLOGY, 2015, 16 (16): : E582 - E583
  • [9] Treatment of Metastatic Colorectal Cancer in the Elderly
    Nguyen, Hong L.
    Hwang, Jimmy
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2009, 10 (5-6) : 287 - 295
  • [10] Panitumumab for the treatment of metastatic colorectal cancer
    Pinguet, Frederic
    [J]. EJHP PRACTICE, 2009, 15 (06): : 66 - 69